Antihypertensive and vasculo- and renoprotective effects of pioglitazone in genetically obese diabetic rats

被引：98

作者：

Yoshimoto, T ^{[1
]}

Naruse, M ^{[1
]}

Nishikawa, M ^{[1
]}

Naruse, K ^{[1
]}

Tanabe, A ^{[1
]}

Seki, T ^{[1
]}

Imaki, T ^{[1
]}

Demura, R ^{[1
]}

Aikawa, E ^{[1
]}

Demura, H ^{[1
]}

机构：

[1] TOKYO WOMENS MED COLL, DEPT ANAT & DEV BIOL, TOKYO 162, JAPAN

来源：

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM | 1997年 / 272卷 / 06期

关键词：

insulin resistance; thiazolidine derivative; insulin-sensitizing agent; diabetic complications;

D O I：

10.1152/ajpendo.1997.272.6.E989

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Although an improvement of insulin sensitivity has been shown to be a new therapeutic approach for treating diabetes mellitus, details of effects of this treatment on the cardiovascular system and possible renal complications remain unknown. In the present study, we investigated the effects of a thiazolidine derivative, pioglitazone, and examined the insulin-sensitizing action on blood pressure, nephropathy, and vascular changes in genetically obese diabetic Wistar fatty (WF) rats. Pioglitazone (3 mg.kg(-1).day(-1)) was orally administered for 13 wk starting at the age of 5 wk, and the results were compared with those of vehicle-treated WF rats. At the age of 18 wk, vehicle-treated WF rats were associated with mild hypertension, nephropathy with proteinuria, histological glomerular injury, and renal arteriolosclerosis in addition to hyperglycemia, hyperinsulinemia, and hyperlipidemia. Treatment with pioglitazone significantly improved glucose and lipid metabolism. In addition, it lowered blood pressure, decreased proteinuria, and prevented glomerular injury, renal arteriolosclerosis, and aortic medial wall thickening, whereas body weight, food intake, sodium balance, and urinary norepinephrine excretion were significantly increased. These results suggest that the insulin-sensitizing agent pioglitazone is effective in correcting not only glucose and lipid metabolism but also cardiovascular and renal complications in non-insulin-dependent diabetes mellitus.

引用

页码：E989 / E996

页数：8

共 37 条

[1] HIGH GLUCOSE INCREASES DIACYLGLYCEROL MASS AND ACTIVATES PROTEIN-KINASE-C IN MESANGIAL CELL-CULTURES [J].

AYO, SH ;

RADNIK, R ;

GARONI, JA ;

TROYER, DA ;

KREISBERG, JI .

AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 261 (04) :F571-F577

[2]

BRAY GA, 1977, FED PROC, V36, P148

[3]

BROWNLEE M, 1988, NEW ENGL J MED, V318, P1315

[4] BLOOD-PRESSURE-LOWERING BY PIOGLITAZONE - EVIDENCE FOR A DIRECT VASCULAR EFFECT [J].

BUCHANAN, TA ;

MEEHAN, WP ;

JENG, YY ;

YANG, D ;

CHAN, TM ;

NADLER, JL ;

SCOTT, S ;

RUDE, RK ;

HSUEH, WA .

JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (01) :354-360

[5] GLOMERULAR-LESIONS AND URINARY ALBUMIN EXCRETION IN TYPE-I DIABETES WITHOUT OVERT PROTEINURIA [J].

CHAVERS, BM ;

BILOUS, RW ;

ELLIS, EN ;

STEFFES, MW ;

MAUER, SM .

NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (15) :966-970

[6] OVERWEIGHT AND HYPERTENSION - A REVIEW [J].

CHIANG, BN ;

PERLMAN, LV ;

EPSTEIN, FH .

CIRCULATION, 1969, 39 (03) :403-+

[7]

COLCA JR, 1990, NEW ANTIDIABETIC DRU, P255

[8]

DIANI AR, 1988, LESSONS ANIMAL DIABE, V2, P535

[9] PIOGLITAZONE ATTENUATES HYPERTENSION AND INHIBITS GROWTH OF RENAL ARTERIOLAR SMOOTH-MUSCLE IN RATS [J].

DUBEY, RK ;

ZHANG, HY ;

REDDY, SR ;

BOEGEHOLD, MA ;

KOTCHEN, TA .

AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 265 (04) :R726-R732

[10]

HARRIHAR AP, 1993, HYPERTENSION, V21, P1020

← 1 2 3 4 →